期刊文献+

PTPN11基因及幽门螺杆菌与广西柳州地区胃癌易感性关系的研究 被引量:4

Study of PTPN11 and helicobacter pylori with susceptibility to gastric cancer
下载PDF
导出
摘要 目的探讨蛋白酪氨酸磷酸酶非受体型11(PTPN11)基因的多态性及幽门螺杆菌(Hp)感染与广西柳州地区人群胃癌易感性的关系。方法胃癌组(238例)及健康对照组(112例)均来自广西柳州地区。运用聚合酶链反应(PCR)及两步法聚合酶链反应(PCR-CTPP)技术对Hp的尿素酶B亚单位(UreB)基因及PTPN11基因第3内含子2460位点的单链构象多态性进行分析。结果胃癌组Hp阳性率高于健康对照组(59.7%vs 48.2%,P<0.05)。胃癌组等位基因A频率低于对照组,等位基因G频率高于对照组(P<0.05)。2组间PTPN11基因第3内含子2460位点各基因型(G/G型、G/A型和A/A型)频率差异无统计学意义(P>0.05)。与G/G型比较,A/A型和G/A型胃癌易感性在2组间差异无统计学意义(A/A型:OR=0.399,95%CI 0.097~1.641;G/A型:OR=0.642,95%CI 0.397~1.039);但A/A型和G/A型合并后再与G/G型比较,含A基因者胃癌易感性显著降低(OR=0.620,95%CI 0.388~0.992)。结论广西柳州地区的人群中PTPN11第3内含子2460位点携带A基因者胃癌易感性低,而该位点为G/G型及Hp感染者胃癌的易感性高。 Objective To investigate the protein tyrosine phosphatase 11 (PTPN11 ) gene polymorphism and Hp in- fection effect on susceptibility to gastric cancer in Liuzhou area of Guangxi. Methods The research object of gastric cancer group ( n =238) and control group( n= 112) were derived from the Liuzhou area of Guangxi. Using the polymerase chain reaction (PCR) technique analysis of urease B subunit (UreB) gene Hp in two steps, using the polymerase chain reaction (PCR CTPP) technique of single strand conformation polymorphism analysis of position 2460 in intron 3 of the PTPNll. Re- sults The positive rate of Hp in gastric cancer group was higher than that of control group (59.7% vs 48.2%, P 〈 0.05 ). Gastric cancer group and control group individuals of each genotype ( G/G, G/A, and A/A) at position 2460 in intron 3 of the PTPN11 distribution difference frequency was not significant ( P 〉 0.05 ). As the group of high frequency distribution in gastric cancer group was higher than that of G allele of PTPN 11 (84r 5% vs. 78.1% ), the control group and the distribution of allele frequency of A was lower than that ( 15.5% vs. 21.9% ), there was significant difference between the two groups (P 〈 O. 05). Compared with G/G type, A/A type and G/A type differences in susceptibility to gastric cancer was not signifi- cant between the two groups. ( A/A : OR = 0. 399, 95% CI 0. 097 ~ 1. 641 ; G/A : OR = 0. 642, 95% CI 0. 397 - 1. 039 ) ; The comparison of A/A and G/A combined with G/G, A genotype was significantly decreased the risk of stomach cancer ( OR = 0. 620, 95% CI 0.388 - 0.992). Conclusion Carrying the A genotype in Liuzhou area of Guangxi individual at posi- tion 2460 in intron 3 of the PTPN11 for gastric cancer risk is significantly reduced, and the site for the association of G/G gene and Hp infection in gastric cancer is high.
出处 《疑难病杂志》 CAS 2013年第6期436-438,共3页 Chinese Journal of Difficult and Complicated Cases
基金 广西壮族自治区卫生厅科研基金项目(No.Z2009325)
关键词 蛋白酪氨酸磷酸酶非受体型11 幽门螺杆菌 胃癌 基因多态性 Protein tyrosine phosphatase 11 Helicobacter pylori Gastric cancer Gene polymorphysim
  • 相关文献

参考文献12

二级参考文献82

共引文献58

同被引文献40

  • 1胃癌诊疗规范(2011年版)[J].中国医学前沿杂志(电子版),2012,4(5):62-71. 被引量:246
  • 2Park J, Scherer R. Adipocyte-derived endotrophin promotes malignant tumor progression [ J ]. Journal of Clinical Investigation, 2012, 122 ( 11 ) :4243.
  • 3Calon A, Espinet E, Palomo-Ponce S, et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initia- tion [J]. Cancer Cell, 2012,22(5) :571-584.
  • 4Ueno H, Mochizuki H, Shirouzu K, et al. Multicenter study for optimal categorization of extramural tumor : deposits for colorectal cancer staging [J]. Annals of Surgery,2012,255(4) :739.
  • 5Halford MM, Tebbutt NC, Desai J, et al. Towards the biomarker-guided rational use of antiangiogenic agents in the treatment of metastatic color- ectal cancer[ J]. Colorectal Cancer,2012,1 (2) : 149-161.
  • 6Allen WL, Stevenson L, Coyle VM, et al. A systems biology approach i- dentifies SART1 as a noveldeterminant of both 5-fluorouracil and SN38 drug resistance in colorectal cance[ J]. Molecular Cancer Therapeutics, 2012,11(1) :119-131.
  • 7Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008 [ J ]. Journal of Clin- ical Oncology,2012,30(4) :401-405.
  • 8Fujioka N, Bitterman PB. Molecular targeted therapy in lung cancer [J]. Minnesota Medicine,2012,95(10) :38.
  • 9Trotti A,Byhardt R,Stetz J,et al.Common toxicity criteria:version 2[J].O.an improved reference for grading the acute effects of cancer treatment:impact on radiotherapy[J].Int J Radiat Oncol Biol Phys,2000,47(1):13-47.
  • 10Giuliani F,Gebbia V,De Vita F,et al.Docetaxel as salvagetherapy in advanced gastric canlcer:a phaseⅡstudy of the Gruppo oncologico 1-talia Meridionale(G.O.I.M.)[J].Anticancer Res,2003,23(5b):4219.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部